Prioritizing Equity in Antimicrobial Stewardship Efforts (EASE): a framework for infectious diseases clinicians.

Autor:	Abdul-Mutakabbir JC; Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA 92093, USA.; Division of Black Diaspora and African American Studies, University of California San Diego, La Jolla, CA 92093, USA., Tan KK; Loma Linda University Medical Center, Department of Pharmacy, Loma Linda, CA, USA.; Loma Linda University School of Pharmacy, Loma Linda, CA 92374, USA., Johnson CL; Department of Pediatrics, Division of Pediatric Infectious Diseases, Columbia University Irving Medical Center, New York, NY 10032, USA.; Department of Infection Prevention and Control, NewYork-Presbyterian Hospital, New York, NY 10032, USA., McGrath CL; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Washington School of Medicine, Seattle, WA 98105, USA., Zerr DM; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Washington School of Medicine, Seattle, WA 98105, USA., Marcelin JR; Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Jazyk:	angličtina
Zdroj:	Antimicrobial stewardship & healthcare epidemiology : ASHE [Antimicrob Steward Healthc Epidemiol] 2024 May 03; Vol. 4 (1), pp. e74. Date of Electronic Publication: 2024 May 03 (Print Publication: 2024).
DOI:	10.1017/ash.2024.69
Abstrakt:	Health equity gaps persist across minoritized groups due to systems of oppression affecting health-related social needs such as access to transportation, education and literacy, or food and housing security. Consequently, disparities in the prevalence of multidrug-resistant infections, infectious disease outcomes, and inappropriate antimicrobial use have been reported across minoritized populations. The Joint Commission and Centers for Medicare and Medicaid Services (CMS) have formally acknowledged the importance of integrating health equity-focused initiatives into existing hospital quality improvement (QI) programs. Here, we review documented disparities in antimicrobial stewardship and offer a framework, derived from components of existing health equity and QI tools, to guide clinicians in prioritizing equity in antimicrobial stewardship efforts (EASE). Competing Interests: JAM has served on advisory boards and received an honorarium for Shionogi, GSK, NovaVax, CSL Sequiris, Innoviva Specialty Therapeutics, and Abbvie. She has also received research support from CSL Sequiris. DMZ has received research funding from Merck and served on end point adjudication committees for AlloVir. All other authors have nothing to disclose relevant to this publication. (© The Author(s) 2024.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu